Melatonin inhibits glucocorticoid-dependent GR-TIF2 interaction in newborn hamster kidney (BHK) cells

Molecular and Cellular Endocrinology

Volumn 349, Issue 2, 2012, Pages 214-221

  Presman, Diego M ^a,b   Levi, Valeria ^a   Pignataro, Omar P ^a,c   Pecci, Adali ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO DE FISIOLOGÍA   (Argentina)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Antagonism; Glucocorticoids; Luzindole; Melatonin; TIF2

Indexed keywords

CYCLIC AMP; GLUCOCORTICOID RECEPTOR; LUZINDOLE; MELATONIN; NUCLEAR RECEPTOR COACTIVATOR 2; DEXAMETHASONE; GLUCOCORTICOID; MELATONIN RECEPTOR; TRYPTAMINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIMERIZATION; DOWN REGULATION; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; HAMSTER; HOMODIMERIZATION; IMMUNOPRECIPITATION; KIDNEY CELL CULTURE; NERVE CELL; NEWBORN; NONHUMAN; NUCLEAR IMPORT; OLIGOMERIZATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; THYMOCYTE; TRANSCRIPTION INITIATION; ACTIVE TRANSPORT; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE MAMMARY TUMOR ONCOVIRUS; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; CRICETINAE; CYCLIC AMP; DEXAMETHASONE; DIMERIZATION; GENE EXPRESSION; GLUCOCORTICOIDS; IMMUNOPRECIPITATION; MAMMARY TUMOR VIRUS, MOUSE; MELATONIN; MICROSCOPY, FLUORESCENCE; NUCLEAR RECEPTOR COACTIVATOR 2; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION; TRYPTAMINES;

EID: 84862623288     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.10.026     Document Type: Article

References (45)

1. Blackhurst G., McElroy P.K., Fraser R., Swan R.L., Connell J.M. Seasonal variation in glucocorticoid receptor binding characteristics in human mononuclear leucocytes. Clin. Endocrinol. (Oxf.) 2001, 55(5):683-688.
2. Boutin J.A., Audinot V., Ferry G., Delagrange P. Molecular tools to study melatonin pathways and actions. Trends Pharmacol. Sci. 2005, 26(8):412-419.
3. Cabrera J., Quintana J., Reiter R.J., Loro J., Cabrera F., Estevez F. Melatonin prevents apoptosis and enhances HSP27 mRNA expression induced by heat shock in HL-60 cells: possible involvement of the MT2 receptor. J. Pineal Res. 2003, 35(4):231-238.
4. Collingwood T.N., Urnov F.D., Wolffe A.P. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endocrinol. 1999, 23(3):255-275.
5. De Bosscher K., Haegeman G. Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol. Endocrinol. 2009, 23(3):281-291.
6. Del Punta K., Charreau E.H., Pignataro O.P. Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 1996, 137(12):5337-5343.
7. del Rio B., Garcia Pedrero J.M., Martinez-Campa C., Zuazua P., Lazo P.S., Ramos S. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J. Biol. Chem. 2004, 279(37):38294-38302.
8. Digman M.A., Dalal R., Horwitz A.F., Gratton E. Mapping the number of molecules and brightness in the laser scanning microscope. Biophys. J. 2008, 94(6):2320-2332.
9. Dong Q., Salva A., Sottas C.M., Niu E., Holmes M., Hardy M.P. Rapid glucocorticoid mediation of suppressed testosterone biosynthesis in male mice subjected to immobilization stress. J. Androl. 2004, 25(6):973-981.
10. Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann. NY Acad. Sci. 2004, 1024:124-137.
11. Galigniana M.D., Scruggs J.L., Herrington J., Welsh M.J., Carter-Su C., Housley P.R., Pratt W.B. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol. Endocrinol. 1998, 12(12):1903-1913.
12. Godowski P.J., Rusconi S., Miesfeld R., Yamamoto K.R. Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature 1987, 325(6102):365-368.
13. Hevia D., Sainz R.M., Blanco D., Quiros I., Tan D.X., Rodriguez C., Mayo J.C. Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion. J. Pineal Res. 2008, 45(3):247-257.
14. Hoijman E., Rocha Viegas L., Keller Sarmiento M.I., Rosenstein R.E., Pecci A. Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin. Endocrinology 2004, 145(1):418-425.
15. Horwitz K.B., Zava D.T., Thilagar A.K., Jensen E.M., McGuire W.L. Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res. 1978, 38(8):2434-2437.
16. Htun H., Barsony J., Renyi I., Gould D.L., Hager G.L. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. USA 1996, 93(10):4845-4850.
17. Iwasaki Y., Aoki Y., Katahira M., Oiso Y., Saito H. Non-genomic mechanisms of glucocorticoid inhibition of adrenocorticotropin secretion: possible involvement of GTP-binding protein. Biochem. Biophys. Res. Commun. 1997, 235(2):295-299.
18. Kassel O., Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol. Cell Endocrinol. 2007, 275(1-2):13-29.
19. Laothong U., Pinlaor P., Hiraku Y., Boonsiri P., Prakobwong S., Khoontawad J., Pinlaor S. Protective effect of melatonin against Opisthorchis viverrini-induced oxidative and nitrosative DNA damage and liver injury in hamsters. J. Pineal Res. 2010, 49(3):271-282.
20. Li X., Wong J., Tsai S.Y., Tsai M.J., O'Malley B.W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell Biol. 2003, 23(11):3763-3773.
21. Lippman M., Bolan G., Huff K. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976, 36:4610-4618.
22. Masana M.I., Doolen S., Ersahin C., Al-Ghoul W.M., Duckles S.P., Dubocovich M.L., Krause D.N. MT(2) melatonin receptors are present and functional in rat caudal artery. J. Pharmacol. Exp. Ther. 2002, 302(3):1295-1302.
23. Mathes A.M., Wolf B., Rensing H. Melatonin receptor antagonist luzindole is a powerful radical scavenger in vitro. J. Pineal Res. 2008, 45(3):337-338.
24. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 1999, 69(1-6):3-12.
25. Milczarek R., Hallmann A., Sokolowska E., Kaletha K., Klimek J. Melatonin enhances antioxidant action of alpha-tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human placental mitochondria. J. Pineal Res. 2010, 49(2):149-155.
26. Mondillo C., Pagotto R.M., Piotrkowski B., Reche C.G., Patrignani Z.J., Cymeryng C.B., Pignataro O.P. Involvement of nitric oxide synthase in the mechanism of histamine-induced inhibition of Leydig cell steroidogenesis via histamine receptor subtypes in Sprague-Dawley rats. Biol. Reprod. 2009, 80(1):144-152.
27. Necela B.M., Cidlowski J.A. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc. Am. Thorac. Soc. 2004, 1(3):239-246.
28. Nelson R.J., Drazen D.L. Melatonin mediates seasonal adjustments in immune function. Reprod. Nutr. Dev. 1999, 39(3):383-398.
29. Nojek I.M., Werbajh S.E., Colo G.P., Rubio F.M., Franco L.D., Nahmod V.E., Costas M.A. Different enzymatic activities recruitment by specific domains of TIF2 are involved in NF-kappaB transactivation. Medicina (B Aires) 2004, 64(2):135-138.
30. Pandit S., Geissler W., Harris G., Sitlani A. Allosteric effects of dexamethasone and RU486 on glucocorticoid receptor-DNA interactions. J. Biol. Chem. 2002, 277(2):1538-1543.
31. Persengiev S.P. Multiple domains of melatonin receptor are involved in the regulation of glucocorticoid receptor-induced gene expression. J. Steroid Biochem. Mol. Biol. 1999, 68(5-6):181-187.
32. Pratt W.B., Galigniana M.D., Morishima Y., Murphy P.J. Role of molecular chaperones in steroid receptor action. Essays Biochem. 2004, 40:41-58.
33. Presman D.M., Alvarez L.D., Levi V., Eduardo S., Digman M.A., Marti M.A., Veleiro A.S., Burton G., Pecci A. Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids. PLoS One 2010, 5(10):e13279.
34. Presman D.M., Hoijman E., Ceballos N.R., Galigniana M.D., Pecci A. Melatonin inhibits glucocorticoid receptor nuclear translocation in mouse thymocytes. Endocrinology 2006, 147(11):5452-5459.
35. Provinciali M., Di Stefano G., Bulian D., Tibaldi A., Fabris N. Effect of melatonin and pineal grafting on thymocyte apoptosis in aging mice. Mech. Ageing Dev. 1996, 90(1):1-19.
36. Quiros I., Mayo J.C., Garcia-Suarez O., Hevia D., Martin V., Rodriguez C., Sainz R.M. Melatonin prevents glucocorticoid inhibition of cell proliferation and toxicity in hippocampal cells by reducing glucocorticoid receptor nuclear translocation. J. Steroid Biochem. Mol. Biol. 2008, 110(1-2):116-124.
37. Reiter R.J., Tan D.X., Fuentes-Broto L. Melatonin: a multitasking molecule. Prog. Brain Res. 2010, 181:127-151.
38. Roca A.L., Godson C., Weaver D.R., Reppert S.M. Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology 1996, 137(8):3469-3477.
39. Sainz R.M., Mayo J.C., Reiter R.J., Antolin I., Esteban M.M., Rodriguez C. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J. 1999, 13(12):1547-1556.
40. Sainz R.M., Mayo J.C., Uria H., Kotler M., Antolin I., Rodriguez C., Menendez-Pelaez A. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res. 1995, 19(4):178-188.
41. Truss M., Bartsch J., Schelbert A., Hache R.J., Beato M. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J. 1995, 14(8):1737-1751.
42. van Steensel B., Brink M., van der Meulen K., van Binnendijk E.P., Wansink D.G., de Jong L., de Kloet E.R., van Driel R. Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. J. Cell Sci. 1995, 108(Pt. 9):3003-3011.
43. Vanecek J. Cellular mechanisms of melatonin action. Physiol. Rev. 1998, 78(3):687-721.
44. Viegas L.R., Vicent G.P., Baranao J.L., Beato M., Pecci A. Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4. J. Biol. Chem. 2004, 279(11):9831-9839.
45. Xu J., Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 2003, 17(9):1681-1692.